Stefano Pessina has entered a new phase in the evolution of his pharmacy empire, overseeing a strategic restructuring that could ultimately lead to the sale of its individual components, including Boots…
The move follows decades of expansion that saw the group grow into a global healthcare and retail powerhouse. As reported by, following an interview with, the Financial Times, the Monegasque billionaire recently led a $23.7 billion buyout of Walgreens Boots Alliance alongside private equity partner Sycamore. Since then, the business has been reorganised into separate entities, marking a clear shift away from the integrated model that once defined its strategy.
While no immediate disposals have been confirmed, the structure now in place allows for the potential sale of individual units over time. Private equity involvement typically implies an eventual exit, and Pessina himself has indicated that decisions on future ownership will come once the reorganisation delivers stronger operational results.
The group’s transformation follows a prolonged decline in valuation, driven by industry pressures including tighter margins, rising competition and broader changes in global supply chains. Against this backdrop, breaking the business into more focused units is seen as a way to unlock value.
Boots, one of the most recognisable assets within the group, has recently shown improved performance in the UK, potentially strengthening its appeal to future buyers.
For now, the focus remains on stabilising and restructuring, but the long-term direction is clear; a controlled dismantling designed to rebuild value piece by piece.